In non-metastatic locally advanced BC patients including a total of 18% TNBC patients, our study group recently demonstrated that high levels of vesicular-bound HLA-G before CT were associated with stem cell like CTC as well as with early disease progression (38). The gene discussed is HLA-G; the disease is breast cancer.